Heart failure (Q53998058)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15924986 AND SRC:MED&resulttype=core&format=json

12 January 2020

review article

1 reference

title

Heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15924986 AND SRC:MED&resulttype=core&format=json

12 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15924986 AND SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Marc A Pfeffer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15924986 AND SRC:MED&resulttype=core&format=json

12 January 2020

language of work or name

English

0 references

publication date

1 May 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15924986 AND SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15924986 AND SRC:MED&resulttype=core&format=json

12 January 2020

volume

365

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15924986 AND SRC:MED&resulttype=core&format=json

12 January 2020

issue

9474

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15924986 AND SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

1877-1889

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15924986 AND SRC:MED&resulttype=core&format=json

Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The Cardiovascular Health Study

12 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Congestive heart failure in old age: prevalence, mechanisms and 4-year prognosis in the Helsinki Ageing Study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Left ventricular systolic dysfunction in 75-year-old men and women; a population-based study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Cross sectional study estimating prevalence of heart failure and left ventricular systolic dysfunction in community patients at risk

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Prevalence of heart failure in Asturias (a region in the north of Spain).

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Prevalence of chronic heart failure in Southwestern Europe: the EPICA study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

The epidemiology of heart failure: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Lifetime Risk for Developing Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Long-Term Trends in the Incidence of and Survival with Heart Failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Trends in Heart Failure Incidence and Survival in a Community-Based Population

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Heart failure and the aging population: an increasing burden in the 21st century?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Trends in hospitalization for heart failure in Scotland, 1990–1996. An epidemic that has reached its peak?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Angiotensin converting enzyme inhibition and hospitalisation rates for heart failure in the Netherlands, 1980 to 1999: the end of an epidemic?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Hospitalization of patients with heart failure: a population-based study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Prognosis for patients newly admitted to hospital with heart failure: survival trends in 12 220 index admissions in Leicestershire 1993-2001

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Trends in heart failure outcomes and pharmacotherapy: 1992 to 2000.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Mortality trends for 23,505 Medicare patients hospitalized with heart failure in Northeast Ohio, 1991 to 1997.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Detecting early clinical deterioration in chronic heart failure patients post-acute hospitalisation-a critical component of multidisciplinary, home-based intervention?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

The current cost of heart failure to the National Health Service in the UK.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Survival of patients with a new diagnosis of heart failure: a population based study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

The epidemiological enigma of heart failure with preserved systolic function

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Heart failure with preserved systolic function. A different natural history?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Diastolic heart failure: neglected or misdiagnosed?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Prevalence of diastolic dysfunction as a possible cause of dyspnea in the elderly

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Echocardiographic indices of left ventricular diastolic dysfunction in 647 individuals with preserved left ventricular systolic function.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

The epidemiological features of heart failure in developing countries: a review of the literature.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Prevalence and aetiology of heart failure in an Arab population

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Congestive heart failure in Latin America: the next epidemic

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

The growing burden of heart failure: the "syndemic" is reaching Latin America

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Hibernation and heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Cardiomyopathy and heart failure in diabetes

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Ventricular remodeling in heart failure: a credible surrogate endpoint

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Genomics and the pathophysiology of heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Matrix metalloproteinases in pathophysiology and treatment of heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Apoptosis: a pivotal event or an epiphenomenon in the pathophysiology of heart failure?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Importance of neuroendocrine activation in chronic heart failure. Impact on treatment strategies

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Inflammatory mediators in chronic heart failure: an overview

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Pathophysiology of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Introduction to atrial fibrillation and heart failure: a mutually noxious association

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Cardiac resynchronisation therapy: when the drugs don't work

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Poor concordance of commonly used echocardiographic measures of left ventricular diastolic function in patients with suspected heart failure but preserved systolic function: is there a reliable echocardiographic measure of diastolic dysfunction?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Heart failure with a normal ejection fraction: is it really a disorder of diastolic function?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

The pathogenesis of acute pulmonary edema associated with hypertension

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Anemia and its relationship to clinical outcome in heart failure.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Depression: are we ignoring an important comorbidity in heart failure?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Treatment of heart failure in older persons. Dilemmas with coexisting conditions: diabetes mellitus, chronic obstructive pulmonary disease, and arthritis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Therapeutic update: non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Pharmacotherapy for heart failure in patients with renal insufficiency

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Assessing diagnosis in heart failure: which features are any use?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Utility of history, physical examination, electrocardiogram, and chest radiograph for differentiating normal from decreased systolic function in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Gu

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

The utility of a comprehensive cardiac magnetic resonance examination for the evaluation of patients with heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Defining diastolic heart failure: a call for standardized diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

European reference values for Doppler indices of left ventricular diastolic filling

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Plasma brain natriuretic peptide concentration: impact of age and gender

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Should B-type natriuretic peptide be measured routinely to guide the diagnosis and management of chronic heart failure?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Exercise training in patients with chronic heart failure: Authors' reply.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

A practical guide to exercise training for heart failure patients

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: results of the Exercise in Left Ventricular Dysfunction and Chronic Heart Failure (ELVD-CHF) Trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Effect of candesartan on New York Heart Association functional class. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Sustained reduction of aldosterone in response to the angiotensin receptor blocker valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Effect of Valsartan on hospitalization: results from Val-HeFT.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

The effect of digoxin on mortality and morbidity in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Digitalis for treatment of congestive heart failure in patients in sinus rhythm: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Clinical practice. Diastolic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigators.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Aldosterone blockade in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

1 reference

7 January 2021

Keeping your patient with heart failure safe: a review of potentially dangerous medications

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Mechanisms and treatment of anemia in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Light-to-moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Effects of exercise training in patients with heart failure: the Exercise Rehabilitation Trial (EXERT).

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Psychological factors in heart failure: a review of the literature

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema; effects on plasma brain natriuretic peptide concentrations

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Discharge education improves clinical outcomes in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Design and methodology of the COACH study: a multicenter randomised Coordinating study evaluating Outcomes of Advising and Counselling in Heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Retiming the failing heart: principles and current clinical status of cardiac resynchronization

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Systematic review: cardiac resynchronization in patients with symptomatic heart failure.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Cardiac resynchronization therapy: caveat medicus!

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Cardiac pacing: the state of the art.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

The effect of cardiac resynchronization on morbidity and mortality in heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Patient Selection for Cardiac Resynchronization Therapy

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Established and evolving indications for cardiac resynchronisation

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Is it time for a randomized trial of surgical treatment of ischemic heart failure?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

The heart failure revascularisation trial (HEART): rationale, design and methodology.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

What is the optimal medical management of ischaemic heart failure?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult lung and heart-lung transplant report--2004.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Potential applications and prospects for cardiac xenotransplantation

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Long-term use of a left ventricular assist device for end-stage heart failure.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Left ventricular assist devices as destination therapy: a new look at survival

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Cardiac replacement with a total artificial heart as a bridge to transplantation

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Ventricular constraint in severe heart failure halts decline in cardiovascular function associated with experimental dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Acute ventricular reduction with the acorn cardiac support device: effect on progressive left ventricular dysfunction and dilation in dogs with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Myosplint decreases wall stress without depressing function in the failing heart: a finite element model study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Myoblast transfer in heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Gene therapy in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Gene and cell-based therapies for heart disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Consensus statement: Palliative and supportive care in advanced heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Palliative care for patients with heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Catheter ablation for atrial fibrillation in congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Targeting phospholamban by gene transfer in human heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III - IV congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(05)66621-4

7 January 2021

10.1016/S0140-6736(05)66621-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15924986 AND SRC:MED&resulttype=core&format=json

12 January 2020

1 reference